EP3222277
Bífenýlsúlfonamíðendóþelín og angíótensín II viðtakamótlyf til að meðhöndla nýrnahnoðrahersli og Ig-A framkallaðan nýrnakvilla
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
29.3.2010EP published:
26.2.2020EP application number:
17157697.8
EP translation filed:
24.4.2020Grant published:
15.5.2020EPO information:
European Patent Register
Max expiry date:
28.3.2030Expiry date:
28.3.2027Next due date:
31.3.2027
Title:
A BIPHENYLSULFONAMIDE ENDOTHELIN AND ANGIOTENSIN II RECEPTOR ANTAGONIST TO TREAT GLOMERULOSCLEROSIS AND IGA-INDUCED NEPHROPATHY
Timeline
Today
29.3.2010EP application
26.2.2020EP Publication
24.4.2020Translation submitted
15.5.2020Registration published
28.3.2027Expires
Owner
Name:
Ligand Pharmaceuticals Inc.Address:
3911 Sorrento Valley Boulevard Suite 110, San Diego, CA 92121, US
Inventor
Name:
Zhang, JinkunAddress:
San Diego, CA California 92128, US
Name:
Dziewanowska, Zofia EAddress:
La Jolla, CA California 92037, US
Name:
Belder, ReneAddress:
Hopewell, NJ New Jersey 08525, US
Name:
Henderson, IanAddress:
San Diego, CA California 92122, US
Name:
Bogardus, Joseph BAddress:
Keene, NY New York 12942, US
Name:
Zhang, ZhaoyingAddress:
Monroe, NJ New Jersey 08831, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
165419 PDate:
31.3.2009Country:
US
Number:
165447 PDate:
31.3.2009Country:
US
Supplementary protection
SPC number:
SPC481
Classification
Categories:
A61K 31/422, A61P 9/12, A61K 9/20, A61P 13/12
Annual fees
Number
Paid
Expires
Payer
Number: 11
Paid: 31.3.2020
Expires: 28.3.2021
Payer: Sigurjónsson & Thor ehf.
Number: 12
Paid: 2.3.2021
Expires: 28.3.2022
Payer: Sigurjónsson & Thor ehf.
Number: 13
Paid: 2.3.2022
Expires: 28.3.2023
Payer: Patice ehf.
Number: 14
Paid: 9.3.2023
Expires: 28.3.2024
Payer: Árnason Faktor ehf.
Number: 15
Paid: 6.3.2024
Expires: 28.3.2025
Payer: Árnason Faktor ehf.
Number: 16
Paid: 4.3.2025
Expires: 28.3.2026
Payer: Árnason Faktor ehf.
Number: 17
Paid: 27.3.2026
Expires: 28.3.2027
Payer: Árnason Faktor ehf.